Pacira Pharmaceuticals, Inc
Nasdaq PCRX · Brisbane, CA
Works in Metabolic & endocrine · Musculoskeletal · Neurology
Pacira Pharmaceuticals, Inc is a clinical trial sponsor based in Brisbane, CA, listed as Nasdaq PCRX. It has 6 active clinical trials with 10,537 planned participants, in Metabolic & endocrine, Musculoskeletal and Neurology. Since 2021 it has completed 46 trials and stopped 11 early.
Trial track record · since 2021
Financials · Nasdaq PCRX
Pipeline · 6 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
2 approved drug applications with a product on the market.
Questions about Pacira Pharmaceuticals, Inc
Pacira Pharmaceuticals, Inc is lead sponsor of 6 active clinical trials on ClinicalTrials.gov, with 10,537 planned participants, in Metabolic & endocrine, Musculoskeletal, Neurology. Since 2021 it has completed 46 trials and stopped 11 early.
Pacira Pharmaceuticals, Inc is based in Brisbane, CA and is listed as Nasdaq PCRX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Pacira Pharmaceuticals, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-17.
Approve Suite is not affiliated with Pacira Pharmaceuticals, Inc.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.